Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare... by Hiroo Imai, Ken Saijo, Hideharu Yamada, Kota Ohuchi, Yoshinari Okada, Keigo Komine, Masahiro Takahashi, Shin Takahashi, Masanobu Takahashi, Hideki Shimodaira, Chikashi Ishioka

Get full text